Compare Exelon Corporation Common Stock (EXC) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelon Corporation Common Stock vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Exelon Corporation Common Stock trades at $41.8 (market cap $42.99B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.65 (market cap $2.27B). The key difference: Exelon Corporation Common Stock is far larger — about 18.9× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Exelon Corporation Common Stock pays a 4.03% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| EXC | SLS | |
|---|---|---|
Market Cap | $42.99B | $2.27B |
Volume | 7,570,408 | 4,179,659 |
Sector | Utilities | Health |
52-Week High | $50.29 | $15.46 |
52-Week Low | $40.20 | $1.39 |
Enterprise Value | $93.85B | $2.14B |
Dividend Yield | 4.03% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Exelon Corporation Common Stock
Exelon is the parent company of six regulated electric and natural gas utilities. Its utilities include Atlantic City Electric, BGE, ComEd, Delmarva Power, PECO, and Pepco.
Read more on EXC →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
